Acute Anterior Uveitis - Initial Management

Key Points

• Anterior-chamber cells and flare are the key slit-lamp findings that distinguish true anterior uveitis from nonspecific red eye.
• Consensual photophobia and ciliary flush support intraocular inflammation but are not diagnostic by themselves.
• Rule out corneal ulcer, acute angle closure, endophthalmitis, open globe, and infectious keratitis before treating presumed noninfectious uveitis.
• Topical corticosteroid is the main treatment for noninfectious anterior uveitis and must be tapered according to objective inflammation.
• Cycloplegic therapy reduces pain and prevents posterior synechiae.
• Check IOP because inflammation and steroid therapy can both produce glaucoma.
• Do not order indiscriminate autoimmune testing for every first episode; use recurrence pattern, laterality, granulomatous features, and systemic symptoms to target the workup.
• Herpetic, syphilitic, tuberculous, and other infectious forms require pathogen-directed therapy in addition to or instead of routine steroid treatment.

Algorithm

1. Assess visual acuity, pupils, cornea, IOP when safe, and slit-lamp anterior chamber for cells and flare.
2. Exclude corneal ulcer, angle closure, open globe, endophthalmitis, scleritis, and major trauma.
3. Determine whether disease is isolated anterior uveitis or includes vitreous, retina, or optic nerve involvement.
4. For likely noninfectious anterior uveitis, start ophthalmology-directed topical corticosteroid and cycloplegic therapy.
5. If herpetic or another infectious cause is suspected, add pathogen-specific treatment and coordinate steroid use with ophthalmology.
6. Use targeted systemic testing when disease is recurrent, bilateral, granulomatous, severe, atypical, or associated with systemic symptoms.
7. Reassess anterior-chamber cell grade and IOP and taper steroid according to response.
8. Escalate to uveitis specialist care for chronic, recurrent, steroid-dependent, posterior, or vision-threatening disease.

Clinical Synopsis & Reasoning

Anterior uveitis is inflammation of the iris and anterior ciliary body and is the most common anatomic form of uveitis. Patients typically report unilateral or bilateral ocular pain, photophobia, redness, blurred vision, and sometimes floaters. Ciliary flush around the limbus, consensual photophobia, a constricted or irregular pupil, and anterior-chamber cells and flare on slit lamp are characteristic. Keratic precipitates may be visible on the corneal endothelium. The diagnosis requires a slit-lamp examination; describing any painful red eye as uveitis without documenting anterior-chamber inflammation risks missing keratitis, acute angle closure, scleritis, endophthalmitis, or open-globe trauma.

Causes include idiopathic disease, HLA-B27-associated spondyloarthritis, inflammatory bowel disease, psoriatic arthritis, reactive arthritis, juvenile idiopathic arthritis, sarcoidosis, Behcet disease, syphilis, tuberculosis, herpes viruses, medication reactions, and masquerade syndromes. The pattern guides workup. A first mild unilateral episode in an otherwise healthy adult may not require broad laboratory screening. Recurrent, bilateral, granulomatous, severe, atypical, or treatment-resistant disease warrants targeted testing based on history and examination. Shotgun autoimmune panels have low yield and generate false positives.

Herpetic anterior uveitis deserves special attention because it may produce sectoral iris atrophy, elevated IOP, corneal findings, or reduced corneal sensation and generally requires antiviral therapy in addition to corticosteroid. Syphilis can mimic almost any ocular inflammatory syndrome and should be considered in unexplained, recurrent, or posterior-involving disease. Posterior symptoms, marked visual loss, vitreous inflammation, or retinal lesions expand the diagnosis beyond isolated anterior uveitis and increase urgency.

Treatment Strategy & Disposition

Topical corticosteroid, often prednisolone acetate 1%, is the main treatment for noninfectious anterior uveitis and is dosed according to inflammatory severity, sometimes as frequently as hourly in severe disease. Therapy must be supervised because undertreatment can permit synechiae and chronic inflammation, while prolonged steroid use can cause glaucoma, cataract, and infection. Steroids are tapered according to anterior-chamber cell response rather than stopped abruptly after subjective improvement.

Cycloplegics such as cyclopentolate, homatropine, or atropine reduce painful ciliary spasm and help prevent or break posterior synechiae between iris and lens. Check IOP at baseline and follow-up. Pressure may be elevated from inflammatory trabeculitis or from corticosteroid response. Topical beta-blocker, alpha agonist, or carbonic anhydrase inhibitor can be used according to clinical context; prostaglandin analogues are often not first choice during active inflammation but may be used selectively by ophthalmology.

If infectious uveitis is suspected, pathogen-directed therapy is essential and corticosteroid strategy changes. Herpetic disease typically receives oral antiviral therapy with carefully supervised topical steroid. Syphilitic uveitis is treated as neurosyphilis with IV penicillin. Endogenous endophthalmitis, toxoplasmosis, tuberculosis, and other infections require disease-specific treatment. Urgent ophthalmology evaluation is appropriate for first presentations with substantial pain or visual loss, elevated IOP, corneal involvement, uncertain diagnosis, or posterior-segment findings.

Epidemiology / Risk Factors

• Anterior uveitis is the most common form of uveitis in many clinical settings.
• A substantial proportion of cases remain idiopathic after appropriate evaluation.
• HLA-B27-associated disease is an important recurrent cause in younger and middle-aged adults.
• Infectious causes vary with geography, immune status, exposures, and ocular findings.

Investigations

When to Seek Urgent Help

Pharmacology

Prognosis / Complications

• Most isolated acute anterior uveitis responds well to timely topical therapy.
• Recurrent inflammation can lead to cataract, glaucoma, posterior synechiae, band keratopathy, and cystoid macular edema.
• Visual prognosis is worse when posterior segment inflammation, macular edema, infection, or chronic steroid toxicity develops.
• Identification and control of associated systemic inflammatory disease can reduce recurrence and steroid burden in selected patients.

Patient Education / Counseling

• Explain that steroid drops must be tapered according to examination findings and should not be stopped abruptly without instruction.
• Warn patients to report worsening vision, increasing pain, halos, headache, nausea, or new floaters promptly.
• Discuss temporary blurred near vision and light sensitivity from cycloplegic drops.
• If recurrent disease is linked to a systemic inflammatory disorder, encourage coordinated rheumatology or other specialty care.
• Advise against using old steroid eye drops for a future red eye without examination because infectious keratitis can look similar.

Notes

Uveitis is a diagnosis of anatomy and mechanism, not just a red-eye label. The ED or primary clinician should establish that anterior-chamber inflammation is actually present and identify whether the disease appears confined to the anterior segment. That prevents two major errors: missing a corneal infection and giving unsafe steroid therapy, or missing posterior disease that requires a different urgency and workup.

The workup should be proportional to phenotype. A single typical unilateral episode can often be managed without extensive systemic testing. Recurrent, bilateral, granulomatous, posterior, or atypical disease deserves targeted evaluation for inflammatory and infectious causes. This approach produces a more useful reference article than a long undifferentiated laboratory list.

References

1. American Academy of Ophthalmology Preferred Practice Patterns and Uveitis Resources — Link
2. AAO Herpes Simplex Keratitis Treatment Guideline — Link